Senior private markets executive and operator focusing on growth-stage technology and healthcare investments, with experience leading portfolio transformation, strategic M&A and capital markets execution. Matthew D. Copley brings cross-functional experience sourcing deals, driving operational improvements, and working with management teams to scale revenue and margins; known for active board involvement and structuring equity and debt financing to support expansion.
Senior private markets executive and operator focusing on growth-stage technology and healthcare investments, with experience leading portfolio transformation, strategic M&A and capital markets execution. Matthew D. Copley brings cross-functional experience sourcing deals, driving operational improvements, and working with management teams to scale revenue and margins; known for active board involvement and structuring equity and debt financing to support expansion.
Focuses on growth-stage technology and healthcare companies, prioritizing platform businesses with clear unit economics and scalable go-to-market models. Employs hands-on partnership with founders, combining operational playbooks, strategic M&A and tailored capital structures (equity and debt) to accelerate revenue and margin expansion. Investment decisions favor differentiated product-market fit, predictable recurring revenue, and governance arrangements enabling active board oversight. Balances growth orientation with disciplined downside protection—staging capital, performance-linked instruments and exit planning across three- to seven-year horizons.
Focuses on growth-stage technology and healthcare companies, prioritizing platform businesses with clear unit economics and scalable go-to-market models. Employs hands-on partnership with founders, combining operational playbooks, strategic M&A and tailored capital structures (equity and debt) to accelerate revenue and margin expansion. Investment decisions favor differentiated product-market fit, predictable recurring revenue, and governance arrangements enabling active board oversight. Balances growth orientation with disciplined downside protection—staging capital, performance-linked instruments and exit planning across three- to seven-year horizons.
| Trades 744 | Longs Won 414/744 55% | Profit Factor 5.59 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $212,243.38 |
| Average Win $85,155.07 | Best Trade (Jul 10) $3.11M | Sharpe Ratio -9.23 |
| Average Loss -$19,121.29 | Worst Trade (Jul 17) -$1.06M | Z-Score -1.84 (95.34%) |
| Commissions $0 | Avg. Trade Length 9m 3w 2d | Expectancy $38,903.46 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 9,009 | 8,108 | 7,207 | 6,306 | 5,405 | 4,505 | 3,604 | 2,703 | 1,802 | 901 |